Home » Topics » BioWorld Science

BioWorld Science
RSS

PRKCD targeting found useful against EGFR inhibitor-resistant lung cancer

Jan. 7, 2019

Gilead and Yuhan enter licensing and collaboration agreement to treat NASH-related fibrosis

Jan. 7, 2019

Phase I results reported for oral ferroportin inhibitor VIT-2763

Jan. 7, 2019

CHDI-390576, a novel CNS-penetrant benzhydryl hydroxamic acid class IIa HDAC inhibitor

Jan. 7, 2019

Positive topline results presented from first cohort of phase I/II study of DTX-401

Jan. 7, 2019

Pse-T2 shows promising activity in a mouse wound model infected with MDR strains

Jan. 7, 2019

Obesity may be linked to anxiety via senescence

Jan. 7, 2019

Lundbeck initiates phase II study of Lu-AF-11167 for the treatment of schizophrenia

Jan. 7, 2019

Bionomics initiates phase II MODULATE study of BNC-105 in combination with nivolumab

Jan. 7, 2019

NLRC5, a new diagnostic marker of IgA nephritis and its progression

Jan. 7, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...